foxo4-dri senolytic peptide mechanism inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Class II senolytics inhibit survival
Class II senolytics inhibit survival pathways elicited by senescent Download Scientific Diagram FOXO4 DRI Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Buy FOXO4 DRI 10mg Third Party Tested BioEdge Peptides
Pay in 4 interest-free payments of $6.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



